Serena et al., 2012 - Google Patents
Micro-arrayed human embryonic stem cells-derived cardiomyocytes for in vitro functional assaySerena et al., 2012
View HTML- Document ID
- 14903495019037551052
- Author
- Serena E
- Cimetta E
- Zatti S
- Zaglia T
- Zagallo M
- Keller G
- Elvassore N
- Publication year
- Publication venue
- PLoS One
External Links
Snippet
Introduction The heart is one of the least regenerative organs in the body and any major insult can result in a significant loss of heart cells. The development of an in vitro-based cardiac tissue could be of paramount importance for many aspects of the cardiology …
- 210000004413 Myocytes, Cardiac 0 title abstract description 26
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0657—Cardiomyocytes; Heart cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
- C12N5/0602—Vertebrate cells
- C12N5/067—Hepatocytes
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Serena et al. | Micro-arrayed human embryonic stem cells-derived cardiomyocytes for in vitro functional assay | |
Lundy et al. | Structural and functional maturation of cardiomyocytes derived from human pluripotent stem cells | |
Wang et al. | Biowire model of interstitial and focal cardiac fibrosis | |
Lee et al. | Simultaneous voltage and calcium mapping of genetically purified human induced pluripotent stem cell–derived cardiac myocyte monolayers | |
Sacchetto et al. | Modeling cardiovascular diseases with hiPSC-derived cardiomyocytes in 2D and 3D cultures | |
Herron et al. | Extracellular matrix–mediated maturation of human pluripotent stem cell–derived cardiac monolayer structure and electrophysiological function | |
Sasaki et al. | Contractile force measurement of human induced pluripotent stem cell-derived cardiac cell sheet-tissue | |
Smith et al. | Human iPSC-derived cardiomyocytes and tissue engineering strategies for disease modeling and drug screening | |
Ruan et al. | Mechanical stress conditioning and electrical stimulation promote contractility and force maturation of induced pluripotent stem cell-derived human cardiac tissue | |
Kensah et al. | A novel miniaturized multimodal bioreactor for continuous in situ assessment of bioartificial cardiac tissue during stimulation and maturation | |
Turnbull et al. | Advancing functional engineered cardiac tissues toward a preclinical model of human myocardium | |
Thomas et al. | Cellular and engineered organoids for cardiovascular models | |
US10233415B1 (en) | Microfluidics cell culture device | |
US20180355298A1 (en) | Multi-organ cell culture system and methods of use thereof | |
Zamprogno et al. | Mechanical properties of soft biological membranes for organ-on-a-chip assessed by bulge test and AFM | |
Visone et al. | Enhancing all-in-one bioreactors by combining interstitial perfusion, electrical stimulation, on-line monitoring and testing within a single chamber for cardiac constructs | |
Chen et al. | Phospholamban as a Crucial Determinant of the Inotropic Response of Human Pluripotent Stem Cell–Derived Ventricular Cardiomyocytes and Engineered 3-Dimensional Tissue Constructs | |
Cho et al. | From engineered heart tissue to cardiac organoid | |
Kanda et al. | Deterministic encapsulation of human cardiac stem cells in variable composition nanoporous gel cocoons to enhance therapeutic repair of injured myocardium | |
Guo et al. | Elastomer-grafted iPSC-derived micro heart muscles to investigate effects of mechanical loading on physiology | |
Szepes et al. | Dual function of iPSC-derived pericyte-like cells in vascularization and fibrosis-related cardiac tissue remodeling in vitro | |
Agrawal et al. | Devices and techniques used to obtain and analyze three‐dimensional cell cultures | |
Cagnin et al. | Overview of micro-and nano-technology tools for stem cell applications: micropatterned and microelectronic devices | |
Etezadi et al. | Optimization of a PDMS-based cell culture substrate for high-density human-induced pluripotent stem cell adhesion and long-term differentiation into cardiomyocytes under a xeno-free condition | |
Varzideh et al. | Bioengineering strategies to create 3D cardiac constructs from human induced pluripotent stem cells |